Amy Vakil is an Associate Director and Lead Study Manager in Clinical Operations, Oncology at Merck, with 25 years of experience in the pharmaceutical industry. They have specialized in global trial management across Phases I-IV, with a focus on Phase I trials. Amy has managed numerous clinical studies in a variety of therapeutic areas including oncology, cardiovascular, and immunosuppressive therapy. They hold a Master's degree in Pharmacology from Thomas Jefferson University and a Bachelor's degree in Nutrition Science from Penn State University. Prior to their current role, Amy served in various capacities at notable companies including sanofi-aventis, Johnson & Johnson, and Immunocore.
This person is not in the org chart
This person is not in any teams
This person is not in any offices